Supplementary files

Published: 13 August 2023| Version 1 | DOI: 10.17632/5c4b8f8yxh.1
Contributor:
Q Y ou

Description

A summary about ongoing clinical trials of lenvatinib in combination with different drugs/therapeutic methods

Files

Categories

Drug Resistance in Cancer, Combined Therapy

Licence